1 citations
,
August 2012 The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.
1 citations
,
July 2011 in “Hair transplant forum international” This article reports increased DNA methylation of the androgen receptor gene in the occipital hair follicles of men with androgenetic alopecia but presents no clinical results.
1 citations
,
December 2009 in “Asian Journal of Research in Chemistry” This study developed and validated ultraviolet spectrophotometric and reversed phase high performance liquid chromatographic methods for simultaneously estimating Tamsulosin and Finasteride in tablet form, showing statistical validation and effectiveness in pharmaceutical analysis.
1 citations
,
January 2009 in “Gynecological endocrinology” This article discusses hirsutism, a condition causing excessive hair growth in women, and offers no new clinical results.
January 2025 in “International Research Journal of Innovations in Engineering and Technology” This review discusses the biological mechanisms, preparation techniques, and clinical applications of platelet-rich plasma therapy, highlighting its variable outcomes and potential improvements for efficacy and standardization; it reports no new clinical results.
September 2026 in “bioRxiv (Cold Spring Harbor Laboratory)” This study mapped the development of the human pilosebaceous unit in prenatal scalp skin using multi-modal analysis, finding that epithelial-mesenchymal interactions guide cellular fate and validated tissue-patterning through a hair-bearing skin organoid model.
August 2026 in “International Journal of Cosmetic Science” This study found that shed hairs from the root significantly outnumber broken hairs during hair fall, particularly in Chinese male and female participants, with shedding predominantly occurring during washing.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles information on Musa paradisiaca, highlighting its morphological features, traditional medicinal uses, chemical composition, and pharmacological activities, including anti-diabetic and anti-ulcer properties among others.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review provides an overview of the morphological characteristics, traditional medicinal uses, chemical composition, and pharmacological activities of Musa paradisiaca, highlighting its reported benefits in treating a range of human ailments, including diabetes and ulcers.
July 2026 in “British Journal of Dermatology” This study observed that administering low-dose oral minoxidil during the daytime led to significantly greater hair density improvements in androgenetic alopecia patients compared to nighttime dosing. This suggests that circadian variations in hair follicle biology could be important for optimizing treatment outcomes.
July 2026 in “International Journal For Multidisciplinary Research” In this study, researchers found that EqualsTwo Oil Free Hair Oil significantly reduced hair fall by up to 73.8% and improved hair strength, scalp condition, and growth cycle parameters in pregnant and lactating women over a 30-day period, without adverse effects.
In this study, Neeli Bhringadi hair oil showed statistically significant improvements in hair growth rate, density, thickness, and reduction in premature graying on participants with androgenetic alopecia and hair graying over 120 days, supporting its potential use in integrative hair care.
July 2026 in “Clinical Cosmetic and Investigational Dermatology” In this study, a liposomal-encapsulated Sesbania grandiflora formulation significantly improved hair and scalp health in adults with hair loss over 180 days, showing enhanced hair density, thickness, growth rate, and tensile strength compared to placebo, with no related adverse events reported.
June 2026 in “International Journal of Current Pharmaceutical Review and Research” This study found that combining platelet-rich plasma with topical minoxidil improved hair density and patient satisfaction in androgenetic alopecia patients more than minoxidil alone, with no serious adverse events reported.
This study found that expert consensus endorsed myo-inositol, alone or combined with folic acid and vitamin D₃, as an effective, well-tolerated option for managing acne and hirsutism in PCOS.
June 2026 in “World Journal of Urology” Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.
June 2026 in “Health Nanotechnology” This narrative review suggests that nanoformulated phytochemicals hold promise for managing polycystic ovarian syndrome, but their efficacy and safety compared to standard treatments require further validation through clinical studies.
This study proposed a new standardized in vitro framework using human hair tresses to evaluate cosmetic hair product performance and found significant improvements in hair breakage, tensile strength, shine, volume, and frizz control compared to a control group without such changes.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review explores the complex causes and treatment options for alopecia, emphasizing that current therapies mainly offer symptomatic relief, while new advancements like stem cell approaches and improved drug delivery systems show promise for addressing underlying disease mechanisms.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights that alopecia's complex causes include hormonal, genetic, and environmental factors, and discusses traditional and emerging therapies, suggesting a need for multi-targeted, mechanism-based treatments to improve long-term management and efficacy.
April 2026 in “Journal of the American Academy of Dermatology”
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study developed a natural herbal shampoo using curry leaves as the main ingredient, combined with other natural substances, aiming to enhance hair growth, strength, and natural darkening while reducing hair loss without the risks associated with chemical shampoos.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study developed an antifungal herbal shampoo using curry leaves and other natural ingredients, aiming to enhance hair growth and strength while preventing hair loss without the chemical risks of commercial shampoos.
March 2026 in “Cosmoderma” This clinical study found that using a cream or lotion as an additional treatment alongside standard care for atopic dermatitis significantly reduced symptoms and improved skin moisturization and barrier function within 28 days compared to standard care alone in participants with mild-to-moderate eczema.
February 2026 in “PubMed” This study found that among women with female pattern hair loss, low-dose oral minoxidil improved hair loss severity and quality of life scores despite 71.6% experiencing mild to moderate unwanted hair growth, which most patients did not consider a reason to discontinue treatment.
February 2026 in “Cureus” This study validated that both tape-based and image-based methods for measuring head crown areas, and the CASLite NOVA as well as Image-Pro software for hair count, showed acceptable agreement, supporting their interchangeable use in hair care research settings.
February 2026 in “International Journal of Molecular Sciences” This review explores the potential roles of extracellular vesicles in various medical fields, emphasizing their promise but noting the need for standardization and clinical testing before widespread application.
January 2026 in “Archives of Dermatological Research” This study found that patients who were hospitalized for COVID-19 were more likely to develop telogen effluvium, a type of hair loss, compared to those treated as outpatients, suggesting a link between COVID-19 severity and this condition.
January 2026 in “Figshare” In this study, women with female pattern hair loss using low-dose oral minoxidil reported significant improvements in hair loss severity and quality of life, with most experiencing mild or moderate unwanted hair growth but continuing treatment regardless.
January 2026 in “Figshare” This study found that women with female pattern hair loss experienced improvements in hair loss severity and quality of life from low-dose oral minoxidil use, despite a common side effect of unwanted hair growth, which most did not consider a reason to stop treatment.